Healthcare · Nasdaq · AI-powered stock analysis, 32-signal quality score, SEC EDGAR financials, and institutional holdings. Updated .
DELCATH SYSTEMS, INC. (DCTH) stock profile, AI quality score, and SEC EDGAR financial data, a Healthcare sector company. 13F Pro's AI-powered ranking engine scores DCTH at 54.7/100 on a 32-signal composite quality model, placing it at rank #1,308 of 2,962 stocks — the top half of the AI-ranked universe. DCTH scores in the top quartile across earnings quality (97.4), revenue growth (94.1). Areas of concern include revenue scale (15.0) and profitability (30.5), which score below median versus the broader universe. Shareholder dilution risk is elevated at 6.5/100, reflecting ongoing share issuance or stock-based compensation. Based on the latest XBRL financial filings (Q2 2026), DELCATH SYSTEMS, INC. reports quarterly revenue of $29.1M, net income of $2.7M, free cash flow of $5.2M. Top institutional holders of DCTH by reported 13-F value include Rosalind Advisors, BlackRock, VANGUARD CAPITAL MANAGEMENT, based on the most recent SEC filings. DCTH trades on the Nasdaq exchange and files with the SEC under CIK 872912. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate DCTH daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for DELCATH SYSTEMS, INC. directly from SEC EDGAR.
AI Quality Score
54.7/100
AI Rank
#1,308
Revenue
$29.1M
Net Income
$2.7M
Free Cash Flow
$5.2M
| Period | Form | Revenue | Net income | Operating margin |
|---|---|---|---|---|
| FY 2025 | 10-K | $85.2M | $2.7M | 0.8% |
| FY 2024 | 10-K | $37.2M | $-26.4M | -33.4% |
| FY 2023 | 10-K | $2.1M | $-47.7M | — |
| FY 2022 | 10-K | $2.7M | $-36.5M | — |
| FY 2021 | 10-K | $3.6M | $-25.6M | — |
| FY 2017 | 10-K | $2.7M | $-45.1M | — |
| Institution | Shares | Value | Reported |
|---|---|---|---|
| Rosalind Advisors | 3,300,389 | $41.6M | 2026-06-30 |
| BlackRock | 2,706,802 | $34.1M | 2026-06-30 |
| VANGUARD CAPITAL MANAGEMENT | 1,221,247 | $15.4M | 2026-06-30 |
| Propel Bio Management | 871,460 | $11.0M | 2026-06-30 |
| GEODE CAPITAL MANAGEMENT | 733,115 | $9.2M | 2026-06-30 |
| STATE STREET | 679,280 | $8.6M | 2026-06-30 |
| ALGERT GLOBAL | 580,708 | $7.3M | 2026-06-30 |
| MILLENNIUM MANAGEMENT | 566,371 | $7.1M | 2026-06-30 |
| Divisadero Street Capital Management | 499,796 | $6.3M | 2026-06-30 |
| MORGAN STANLEY | 407,983 | $5.1M | 2026-06-30 |
13F Pro Quality Score
Rank #1,308 of 2,962 stocksTOP 50%
Rankings refresh quarterly once 80% of peers have filed (~45 days after quarter-end). Next update: ~Nov 14, 2026.
Revenue Growth
Profitability
Balance Sheet
Earnings Quality
Free Cash Flow
Institutional Flow
Revenue Scale
Dilution Risk